ResMed, Inc. (RMD)
240.87
-2.21
(-0.91%)
USD |
NYSE |
Dec 31, 16:00
240.90
+0.03
(+0.01%)
Pre-Market: 20:00
ResMed Market Cap: 35.16B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 141.35B |
| Abbott Laboratories | 217.86B |
| Stryker Corp. | 134.41B |
| Becton, Dickinson & Co. | 55.39B |
| West Pharmaceutical Services, Inc. | 19.79B |
Market Cap Related Metrics
| PE Ratio | 24.65 |
| PS Ratio | 6.742 |
| PEG Ratio | 0.8346 |
| Price to Book Value | 5.744 |
| Price to Free Cash Flow | 20.18 |
| Price | 240.87 |
| Earnings Yield | 4.06% |
| PEGY Ratio | 0.8089 |
| Operating PE Ratio | 20.11 |
| Normalized PE Ratio | 24.56 |